78 / 102
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 27, No 3, May/June 2016
200
AFRICA
32. Okpechi IG, Schoeman HS, Longo-Mbenza B,
et al
. Achieving blood
preSsure goals sTudy in uncontrolled hypeRtensive pAtients treated
with a fixed-dose combination of ramipriL/hydrochlorothiazide: the
ASTRAL study.
Cardiovasc J Afr
2011;
22
(2): 79–84.
33. Mayosi BM, Ntsekhe M, Bosch J,
et al.
Rationale and design of the
Investigation of the Management of Pericarditis (IMPI) trial: a 2 ×
2 factorial randomized double-blind multicenter trial of adjunctive
prednisolone and Mycobacterium w immunotherapy in tuberculous
pericarditis.
Am Heart J
2013;
165
(2): 109–115 e3.
34. Owolabi MO, Mensah GA, Kimmel PL,
et al.
Understanding the rise
in cardiovascular diseases in Africa: harmonising H3Africa genomic
epidemiological teams and tools.
Cardiovasc J Afr
2014;
25
(3): 134–136.
35. Sooryamoorthy R. Do types of collaboration change citation?
Collaboration and citation patterns of South African science publica-
tions.
Scientometrics
2009;
81
(1): 177–193.
36. Gazni A, Didegah F. Investigating different types of research collabora-
tion and citation impact: a case study of Harvard University’s publica-
tions.
Scientometrics
2011;
87
(2): 251–265.
Development of the roadmap for reducing cardiovascular
morbidity and mortality through the detection, treatment
and control of hypertension in Africa: report of a working
group of the PASCAR Hypertension Task Force
Anastase Dzudie, Abdoul Kane, Euloge Kramoh, Jean-Baptiste Anzouan-Kacou, Jean Marie Damourou,
Lucien Allawaye, Jolis Nzisabira, Latif Mousse, Dadier Balde, Ouane Nouhom, Jean Louis Nkoa, Kimbally
Kaki, Armel Djomou, Alain Menanga, Christ Nadege Nganou, Jean Bruno Mipinda, Lucie Nebie, Liliane
Mfeukeu Kuate, Samuel Kingue, Serigne Abdou Ba, on behalf of the PASCAR task force on hypertension
Abstract
The fourth Pan-African Society of Cardiology (PASCAR)
hypertension taskforce meeting was held at the Yaoundé
Hilton Hotel on 16 March 2016. Its main goals were to update
and facilitate understanding of the PASCAR roadmap for
the control of hypertension on the continent, to refine the
PASCAR hypertension algorithm, and to discuss the next
steps of the PASCAR hypertension policy, including how the
PASCAR initiative can be customised at country level. The
formation of the PASCAR coalition against hypertension,
the writing group and the current status of the PASCAR
hypertension policy document as well as the algorithm
were presented to delegates representing 12 French-speaking
countries. The urgency to finalise the continental policy was
recognised and consensus was achieved by discussion on
the main points and strategy. Relevant scientific issues were
discussed and comments were received on all points, including
how the algorithm could be simplified and made more acces-
sible for implementation at primary healthcare centres.
Keywords:
hypertension, policy, PASCAR, roadmap, Africa
In sub-Saharan Africa, the high prevalence of hypertension is
coupled with poor rates of detection, treatment and control.
1
The disease is a major threat to achievement of the World
Health Organisation Global Action Plan 2013–2020 for
non-communicable disease (NCD) reduction, specifically focused
on heart attacks, strokes and other cardiovascular diseases.
As the leading continental organisation, the Pan-African
Society of Cardiology (PASCAR), including all hypertension
experts and stakeholders, embarked on the development of a
continental hypertension policy to help reduce heart disease and
stroke on the continent by the year 2025. To achieve its goal,
this coalition started working in 2014,
2
achieving consensus on
a majority of points by group discussion during conference calls
and three face-to-face meetings, as well as by iterative revisions of
the written document. This document, which is a customisation
of the World Heart Federation (WHF) global roadmap
3
to the
Africa-specific context, was discussed and reviewed on several
occasions in opportunistic and scheduled meetings.
Meeting Report